Cleared Traditional

K983102 - CARDIAC DIAGNOSTIC SYSTEM MODEL CH 2000

K983102 is an FDA 510(k) clearance for CARDIAC DIAGNOSTIC SYSTEM MODEL CH 2000, manufactured by Cambridge Heart, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 221-day FDA review.

K983102 · Cambridge Heart, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1999
Decision
221d
Days
Class 2
Risk

K983102 is an FDA 510(k) clearance for the CARDIAC DIAGNOSTIC SYSTEM MODEL CH 2000. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Cambridge Heart, Inc. (South West Ranches, US). The FDA issued a Cleared decision on April 12, 1999 after a review of 221 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Cambridge Heart, Inc. devices

FDA 510(k) Submission Details - K983102

510(k) Number K983102 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 03, 1998
Decision Date April 12, 1999
Days to Decision 221 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
96d slower than avg
Panel avg: 125d · This submission: 221d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 294
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K983102.
MAC-LAB SYSTEM
K992948 · General Electric Medical Systems Information Techn · Nov 1999
SYNEFLASH & SYNEVIEW
K990727 · Ela Medical, Inc. · Nov 1999
CARTO EP NAVIGATION SYSTEM
K992968 · Biosense Webster, Inc. · Sep 1999
NIVP3 (WINDOWS VERSION OF NIVP
K970570 · D. E. Hokanson, Inc. · Oct 1997
SPACELABS MEDICAL ECG ANALYSIS SYSTEM
K962930 · Spacelabs Medical, Inc. · Apr 1997
STRESSWRITER EXERCISE TESTING SYSTEM
K961009 · Hewlett-Packard Co. · Jun 1996